|Bid||27.59 x 1000|
|Ask||27.61 x 800|
|Day's range||26.77 - 27.73|
|52-week range||14.78 - 34.80|
|Beta (5Y monthly)||1.73|
|PE ratio (TTM)||N/A|
|Earnings date||04 Aug 2021 - 09 Aug 2021|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||10 Nov 2010|
|1y target est||35.56|
Bausch (BHC) beats on earnings but misses on sales in the first quarter due to the ongoing pandemic.
These two battered stocks have reignited investors' passion over the past year. Can their momentum last?
Shares of Bausch Health Companies (NYSE: BHC) were falling 9.9% lower as of 11:24 a.m. EDT on Tuesday. Bausch Health reported Q1 revenue of $2.03 billion, up 1% year over year. Ordinarily, mixed quarterly results with a narrow revenue miss wouldn't cause a healthcare stock to sink as much as Bausch Health is falling today.